US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Cellectar Biosciences

2.46

-0.0500-1.99%

Pre-market: 2.570.1100+4.47%07:14 EDT

Volume:46.43K

Turnover:115.98K

Market Cap:23.25M

PE:-1.11

High:2.54

Open:2.48

Low:2.45

Close:2.51

52wk High:6.52

52wk Low:2.20

Shares:9.45M

Float Shares:9.01M

Volume Ratio:2.85

T/O Rate:0.52%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-2.2100

EPS(LYR):-8.3544

ROE:-119.57%

ROA:-58.44%

PB:0.78

PE(LYR):-0.29

Loading ...

Overview Company News Filings

Cellectar Biosciences Q1 EPS $(1.33) Beats $(1.89) Estimate. Cash And Equivalents $8.35M

Benzinga Earnings

Cellectar net loss narrows 12% to $5.7 million in Q1 2026

Cellectar Biosciences Inc expected to post a loss of $1.88 a share - Earnings Preview

Cellectar COO Jarrod Longcor acquires 8,680 shares for $24,998.4

Cellectar CEO James Caruso acquires 8,680 shares worth $24,998.4

Cellectar Biosciences schedules first-quarter results conference call and webcast

Cellectar Biosciences to Report First Quarter Financial Results and Host a Conference Call on Thursday, May 14, 2026

Cellectar Biosciences Inc expected to post a loss of $1.88 a share - Earnings Preview

Cellectar BioSciences sells 2,116,887 unregistered shares in private placement

Cellectar Biosciences price target lowered to $11 from $14 at Roth Capital

Cellectar says iopofosine I 131 posts 61.8% major response rate in Phase 2b WM trial

Cellectar BioSciences prices private placement of shares and warrants at up to $140 million

Cellectar Biosciences Inc - Reports 83.6% Orr, 61.8% Mrr, Median Duration of Response 17.8 Months in Phase 2B Clover Wam

THOMSON REUTERS

Cellectar Biosciences Reports Positive 12-Month Follow-up Data From Phase 2B Clover Wam Study Demonstrating Durable Responses and Efficacy of Iopofosine I 131 in R/R WaldenstrÖM Macroglobulinemia

THOMSON REUTERS

Cellectar Biosciences: Advancing Plans to Initiate a Confirmatory Randomized Study in a Post-First Line, Post-Btki Population

THOMSON REUTERS

Cellectar Biosciences Reports Positive 12-Month Follow-Up Data from Phase 2b CLOVER WaM Study Demonstrating Durable Responses and Efficacy of Iopofosine I 131 in r/r Waldenström Macroglobulinemia

Cellectar Biosciences Inc - Financing Led by Nantahala Capital With Participation From Major Healthcare Investors

THOMSON REUTERS

Press Release: Cellectar Biosciences Announces Oversubscribed Financing Up to $140 Million

Cellectar CLOVER-WaM trial data accepted for ASCO 2026 poster presentation

Cellectar enrolls first patient in Phase 1b CLR 125 trial for TNBC

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigeractivity.com/stock/CLRB/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CLRB","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CLRB\",,,,,undefined,":{"symbol":"CLRB","market":"US","secType":"STK","nameCN":"Cellectar Biosciences","latestPrice":2.46,"timestamp":1788292800000,"preClose":2.51,"halted":0,"volume":46427,"hourTrading":{"tag":"盘前","latestPrice":2.57,"preClose":2.46,"latestTime":"07:14 EDT","volume":2,"amount":5.38,"timestamp":1788347669795,"change":0.11,"changeRate":0.044715,"amplitude":0.097561},"delay":0,"changeRate":-0.019920318725099532,"floatShares":9008238,"shares":9452100,"eps":-2.21,"marketStatus":"Pre-Mkt","change":-0.05,"latestTime":"09-02 07:51:48 EDT","open":2.48,"high":2.54,"low":2.45,"amount":115978.99156719999,"amplitude":0.035857,"askPrice":2.8,"askSize":178,"bidPrice":2.28,"bidSize":221,"shortable":3,"etf":0,"ttmEps":-2.21,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1788355800000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":2.46,"preHourTrading":{"tag":"盘前","latestPrice":2.57,"preClose":2.46,"latestTime":"07:14 EDT","volume":2,"amount":5.38,"timestamp":1788347669795,"change":0.11,"changeRate":0.044715,"amplitude":0.097561},"postHourTrading":{"tag":"盘后","latestPrice":2.46,"preClose":2.46,"latestTime":"19:57 EDT","volume":14,"amount":34.63,"timestamp":1788307076193,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":2.8544464382080914,"impliedVol":1.1856,"impliedVolPercentile":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CLRB\",,,,,undefined,":{"symbol":"CLRB","floatShares":9008238,"roa":"-58.44%","roe":"-119.57%","lyrEps":-8.354443,"volumeRatio":2.8544464382080914,"shares":9452100,"dividePrice":0,"high":2.54,"amplitude":0.035857,"preClose":2.51,"low":2.45,"week52Low":2.2,"pbRate":"0.78","week52High":6.52,"institutionHeld":0,"latestPrice":2.46,"committee":0.107769,"eps":-2.21,"divideRate":0,"volume":46427,"delay":0,"ttmEps":-2.21,"open":2.48,"prevYearClose":2.95,"prevWeekClose":2.53,"prevMonthClose":2.51,"prevQuarterClose":2.78,"fiveDayClose":2.54,"twentyDayClose":2.56,"sixtyDayClose":2.59},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CLRB\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-13","symbol":"CLRB","fiscalQuarterEnding":"2026/06","expectedEps":-0.55,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1786593600000,"reportTimeType":"pre","actualEps":-0.57},{"market":"US","date":"2026-05-14","symbol":"CLRB","fiscalQuarterEnding":"2026/03","expectedEps":-1.35,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1778731200000,"reportTimeType":"pre","actualEps":-1.33},{"market":"US","date":"2026-03-04","symbol":"CLRB","fiscalQuarterEnding":"2025/12","expectedEps":-1.19,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1772600400000,"reportTimeType":"pre","actualEps":-0.53},{"market":"US","date":"2025-11-13","symbol":"CLRB","fiscalQuarterEnding":"2025/09","expectedEps":-1.91,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1763010000000,"reportTimeType":"pre","actualEps":-1.41},{"market":"US","date":"2025-08-14","symbol":"CLRB","fiscalQuarterEnding":"2025/06","expectedEps":-3.6,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1755144000000,"reportTimeType":"pre","actualEps":-3.39}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CLRB\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CLRB\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.25,"buy":0.75,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.75,"analysts":4,"updateTime":1787112000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CLRB\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CLRB","date":"2026-09-01","current":-1.113122,"percent":0.378776,"low":-3.420315,"twenty":-1.540345,"median":-0.817772,"eighty":-0.523306,"high":-0.193553,"avg":-1.095881,"sd":0.772781,"marketCap":23724791},"quantilePoints":[{"date":"2021-09-03","current":-3.160965,"twenty":-5.239728,"median":-1.603144,"eighty":-0.925383,"marketCap":62934297},{"date":"2021-09-10","current":-3.191654,"twenty":-5.239728,"median":-1.603144,"eighty":-0.925383,"marketCap":63545310},{"date":"2021-09-17","current":-3.099587,"twenty":-5.239728,"median":-1.603144,"eighty":-0.925383,"marketCap":61712272},{"date":"2021-09-24","current":-2.999848,"twenty":-5.239728,"median":-1.603144,"eighty":-0.925383,"marketCap":59726481},{"date":"2021-10-01","current":-2.790856,"twenty":-5.239728,"median":-1.603144,"eighty":-0.925383,"marketCap":55565485},{"date":"2021-10-08","current":-2.606722,"twenty":-5.239728,"median":-1.603144,"eighty":-0.925383,"marketCap":51899410},{"date":"2021-10-15","current":-2.814486,"twenty":-5.239728,"median":-1.605688,"eighty":-0.925383,"marketCap":56035965},{"date":"2021-10-22","current":-2.760474,"twenty":-5.239728,"median":-1.616414,"eighty":-0.925383,"marketCap":54960583},{"date":"2021-10-29","current":-2.645697,"twenty":-5.239728,"median":-1.622698,"eighty":-0.925383,"marketCap":52675396},{"date":"2021-11-05","current":-2.874023,"twenty":-5.239728,"median":-1.637244,"eighty":-0.925383,"marketCap":57221329},{"date":"2021-11-12","current":-2.424802,"twenty":-5.239728,"median":-1.64287,"eighty":-0.925383,"marketCap":52907581},{"date":"2021-11-19","current":-2.114246,"twenty":-5.239728,"median":-1.670829,"eighty":-0.925383,"marketCap":46131451},{"date":"2021-11-26","current":-2.024355,"twenty":-5.239728,"median":-1.697872,"eighty":-0.926071,"marketCap":44170100},{"date":"2021-12-03","current":-1.710999,"twenty":-5.239728,"median":-1.7177,"eighty":-0.926481,"marketCap":37332869},{"date":"2021-12-10","current":-2.175853,"twenty":-5.233037,"median":-1.731798,"eighty":-0.926567,"marketCap":47475679},{"date":"2021-12-17","current":-1.932225,"twenty":-5.233037,"median":-1.751184,"eighty":-0.932125,"marketCap":42159869},{"date":"2021-12-23","current":-1.960228,"twenty":-5.233037,"median":-1.764108,"eighty":-0.933139,"marketCap":42770882},{"date":"2021-12-31","current":-1.859416,"twenty":-5.233037,"median":-1.80397,"eighty":-0.933139,"marketCap":40571236},{"date":"2022-01-07","current":-1.931665,"twenty":-5.226345,"median":-1.843174,"eighty":-0.933273,"marketCap":42147649},{"date":"2022-01-14","current":-1.957148,"twenty":-5.226345,"median":-1.894678,"eighty":-0.933273,"marketCap":42703670},{"date":"2022-01-21","current":-1.512176,"twenty":-5.226345,"median":-1.894678,"eighty":-0.933273,"marketCap":32994680},{"date":"2022-01-28","current":-1.651912,"twenty":-5.226345,"median":-1.894678,"eighty":-0.933273,"marketCap":36043633},{"date":"2022-02-04","current":-1.597026,"twenty":-5.226345,"median":-1.880422,"eighty":-0.933273,"marketCap":34846048},{"date":"2022-02-11","current":-1.596186,"twenty":-5.226345,"median":-1.841635,"eighty":-0.933273,"marketCap":34827718},{"date":"2022-02-18","current":-1.365159,"twenty":-5.226345,"median":-1.799558,"eighty":-0.933273,"marketCap":29786864},{"date":"2022-02-25","current":-1.343876,"twenty":-5.226345,"median":-1.772988,"eighty":-0.933273,"marketCap":29322494},{"date":"2022-03-04","current":-1.313353,"twenty":-5.226345,"median":-1.754415,"eighty":-0.933273,"marketCap":28656490},{"date":"2022-03-11","current":-1.382521,"twenty":-5.226345,"median":-1.731798,"eighty":-0.933273,"marketCap":30165692},{"date":"2022-03-18","current":-1.512176,"twenty":-5.156037,"median":-1.7177,"eighty":-0.933273,"marketCap":32994680},{"date":"2022-03-25","current":-1.684679,"twenty":-5.125151,"median":-1.705459,"eighty":-0.933273,"marketCap":40638448},{"date":"2022-04-01","current":-1.747497,"twenty":-5.074166,"median":-1.705459,"eighty":-0.933273,"marketCap":42153759},{"date":"2022-04-08","current":-1.672015,"twenty":-5.004293,"median":-1.688068,"eighty":-0.933273,"marketCap":40332941},{"date":"2022-04-14","current":-1.744204,"twenty":-4.988062,"median":-1.677395,"eighty":-0.933273,"marketCap":42074327},{"date":"2022-04-22","current":-1.499772,"twenty":-4.928004,"median":-1.665722,"eighty":-0.933273,"marketCap":36178050},{"date":"2022-04-29","current":-1.35514,"twenty":-4.81659,"median":-1.653084,"eighty":-0.933273,"marketCap":32689168},{"date":"2022-05-06","current":-1.236093,"twenty":-4.81659,"median":-1.642551,"eighty":-0.933273,"marketCap":29817471},{"date":"2022-05-13","current":-0.971537,"twenty":-4.759432,"median":-1.633772,"eighty":-0.932431,"marketCap":23224585},{"date":"2022-05-20","current":-0.922973,"twenty":-4.707882,"median":-1.622321,"eighty":-0.926654,"marketCap":22063661},{"date":"2022-05-27","current":-1.124386,"twenty":-4.59731,"median":-1.616414,"eighty":-0.924784,"marketCap":26878439},{"date":"2022-06-03","current":-1.06317,"twenty":-4.527041,"median":-1.608334,"eighty":-0.924784,"marketCap":25415064},{"date":"2022-06-10","current":-0.988154,"twenty":-4.346201,"median":-1.599718,"eighty":-0.924784,"marketCap":23621804},{"date":"2022-06-17","current":-0.97895,"twenty":-4.102874,"median":-1.595839,"eighty":-0.922973,"marketCap":23401778},{"date":"2022-06-24","current":-1.052051,"twenty":-3.948352,"median":-1.589635,"eighty":-0.922973,"marketCap":25149274},{"date":"2022-07-01","current":-1.052307,"twenty":-3.872252,"median":-1.579478,"eighty":-0.922973,"marketCap":25155384},{"date":"2022-07-08","current":-1.139722,"twenty":-3.827791,"median":-1.572391,"eighty":-0.922973,"marketCap":27245047},{"date":"2022-07-15","current":-1.098824,"twenty":-3.749427,"median":-1.565438,"eighty":-0.922973,"marketCap":26267366},{"date":"2022-07-22","current":-1.265222,"twenty":-3.691644,"median":-1.559288,"eighty":-0.922973,"marketCap":30245118},{"date":"2022-07-29","current":-1.001954,"twenty":-3.538446,"median":-1.559288,"eighty":-0.922973,"marketCap":23951690},{"date":"2022-08-05","current":-1.249205,"twenty":-3.429942,"median":-1.546185,"eighty":-0.922973,"marketCap":31619886},{"date":"2022-08-12","current":-1.419387,"twenty":-3.357606,"median":-1.540179,"eighty":-0.922973,"marketCap":35927523},{"date":"2022-08-19","current":-1.389213,"twenty":-3.28527,"median":-1.537358,"eighty":-0.922973,"marketCap":35163757},{"date":"2022-08-26","current":-1.286645,"twenty":-3.192932,"median":-1.533081,"eighty":-0.922973,"marketCap":32567566},{"date":"2022-09-02","current":-1.264847,"twenty":-3.164709,"median":-1.533081,"eighty":-0.922973,"marketCap":32015822},{"date":"2022-09-09","current":-1.194892,"twenty":-3.130276,"median":-1.533081,"eighty":-0.922973,"marketCap":30245108},{"date":"2022-09-16","current":-1.136958,"twenty":-3.099587,"median":-1.530339,"eighty":-0.922973,"marketCap":28778679},{"date":"2022-09-23","current":-0.905221,"twenty":-3.052825,"median":-1.523319,"eighty":-0.922253,"marketCap":22912961},{"date":"2022-09-30","current":-0.811078,"twenty":-3.002917,"median":-1.516299,"eighty":-0.919318,"marketCap":20530013},{"date":"2022-10-07","current":-0.808664,"twenty":-2.963818,"median":-1.511365,"eighty":-0.913446,"marketCap":20468912},{"date":"2022-10-14","current":-0.50451,"twenty":-2.902195,"median":-1.509279,"eighty":-0.910753,"marketCap":12770157},{"date":"2022-10-21","current":-0.439334,"twenty":-2.829708,"median":-1.506875,"eighty":-0.901903,"marketCap":11120423},{"date":"2022-10-28","current":-0.778645,"twenty":-2.798958,"median":-1.502259,"eighty":-0.894438,"marketCap":19709071},{"date":"2022-11-04","current":-0.649648,"twenty":-2.772857,"median":-1.500323,"eighty":-0.88915,"marketCap":17738164},{"date":"2022-11-11","current":-0.653085,"twenty":-2.722212,"median":-1.495239,"eighty":-0.886133,"marketCap":17832016},{"date":"2022-11-18","current":-0.684021,"twenty":-2.666626,"median":-1.493772,"eighty":-0.878935,"marketCap":18676691},{"date":"2022-11-25","current":-0.65996,"twenty":-2.645329,"median":-1.492014,"eighty":-0.872388,"marketCap":18019722},{"date":"2022-12-02","current":-0.642774,"twenty":-2.617033,"median":-1.486496,"eighty":-0.866735,"marketCap":17550458},{"date":"2022-12-09","current":-0.603245,"twenty":-2.569255,"median":-1.481199,"eighty":-0.86055,"marketCap":16471152},{"date":"2022-12-16","current":-0.464034,"twenty":-2.517725,"median":-1.478305,"eighty":-0.85454,"marketCap":12670117},{"date":"2022-12-23","current":-0.53278,"twenty":-2.478119,"median":-1.47143,"eighty":-0.849991,"marketCap":14547171},{"date":"2022-12-30","current":-0.587777,"twenty":-2.449284,"median":-1.464554,"eighty":-0.84308,"marketCap":16048815},{"date":"2023-01-06","current":-0.635899,"twenty":-2.449284,"median":-1.457678,"eighty":-0.838184,"marketCap":17362753},{"date":"2023-01-13","current":-0.586058,"twenty":-2.449284,"median":-1.456169,"eighty":-0.826732,"marketCap":16001888},{"date":"2023-01-20","current":-0.519031,"twenty":-2.449284,"median":-1.453935,"eighty":-0.822266,"marketCap":14171760},{"date":"2023-01-27","current":-0.529343,"twenty":-2.449284,"median":-1.449641,"eighty":-0.811174,"marketCap":14453318},{"date":"2023-02-03","current":-0.567153,"twenty":-2.449284,"median":-1.441011,"eighty":-0.810112,"marketCap":15485698},{"date":"2023-02-10","current":-0.58434,"twenty":-2.449284,"median":-1.430175,"eighty":-0.799183,"marketCap":15954962},{"date":"2023-02-17","current":-0.574028,"twenty":-2.449284,"median":-1.425071,"eighty":-0.79354,"marketCap":15673404},{"date":"2023-02-24","current":-0.536218,"twenty":-2.449284,"median":-1.416973,"eighty":-0.786486,"marketCap":14641024},{"date":"2023-03-03","current":-0.646211,"twenty":-2.449284,"median":-1.411924,"eighty":-0.781744,"marketCap":17644311},{"date":"2023-03-10","current":-0.548305,"twenty":-2.449284,"median":-1.404643,"eighty":-0.776181,"marketCap":15682216},{"date":"2023-03-17","current":-0.517655,"twenty":-2.449284,"median":-1.395795,"eighty":-0.774082,"marketCap":14805570},{"date":"2023-03-24","current":-0.514249,"twenty":-2.449284,"median":-1.389315,"eighty":-0.768613,"marketCap":14708165},{"date":"2023-03-31","current":-0.487004,"twenty":-2.44707,"median":-1.388277,"eighty":-0.76466,"marketCap":13928925},{"date":"2023-04-06","current":-0.459759,"twenty":-2.449284,"median":-1.388216,"eighty":-0.761326,"marketCap":13149684},{"date":"2023-04-14","current":-0.469976,"twenty":-2.451499,"median":-1.386252,"eighty":-0.754745,"marketCap":13441899},{"date":"2023-04-21","current":-0.509788,"twenty":-2.451499,"median":-1.37818,"eighty":-0.751061,"marketCap":14580564},{"date":"2023-04-28","current":-0.519357,"twenty":-2.451499,"median":-1.37244,"eighty":-0.748983,"marketCap":14854273},{"date":"2023-05-05","current":-0.504032,"twenty":-2.451499,"median":-1.364402,"eighty":-0.736952,"marketCap":14415950},{"date":"2023-05-12","current":-0.442426,"twenty":-2.451499,"median":-1.363468,"eighty":-0.728012,"marketCap":13734114},{"date":"2023-05-19","current":-0.467528,"twenty":-2.451499,"median":-1.363468,"eighty":-0.723003,"marketCap":14513355},{"date":"2023-05-25","current":-0.480079,"twenty":-2.451499,"median":-1.363468,"eighty":-0.717726,"marketCap":14902975},{"date":"2023-06-02","current":-0.511457,"twenty":-2.453713,"median":-1.363468,"eighty":-0.71595,"marketCap":15877026},{"date":"2023-06-09","current":-0.552248,"twenty":-2.453713,"median":-1.363468,"eighty":-0.711716,"marketCap":17143292},{"date":"2023-06-16","current":-0.643244,"twenty":-2.453713,"median":-1.363468,"eighty":-0.707415,"marketCap":19968039},{"date":"2023-06-23","current":-0.608728,"twenty":-2.455927,"median":-1.363468,"eighty":-0.703804,"marketCap":18896583},{"date":"2023-06-30","current":-0.580488,"twenty":-2.455927,"median":-1.363468,"eighty":-0.701226,"marketCap":18019937},{"date":"2023-07-07","current":-0.621279,"twenty":-2.455927,"median":-1.363468,"eighty":-0.698648,"marketCap":19286203},{"date":"2023-07-14","current":-0.564799,"twenty":-2.455927,"median":-1.363468,"eighty":-0.695814,"marketCap":17532912},{"date":"2023-07-21","current":-0.621279,"twenty":-2.455927,"median":-1.364313,"eighty":-0.6926,"marketCap":19286203},{"date":"2023-07-28","current":-0.593667,"twenty":-2.455927,"median":-1.364313,"eighty":-0.689642,"marketCap":18429039},{"date":"2023-08-04","current":-0.555386,"twenty":-2.455927,"median":-1.364313,"eighty":-0.684662,"marketCap":17240697},{"date":"2023-08-11","current":-0.542835,"twenty":-2.455927,"median":-1.364313,"eighty":-0.682685,"marketCap":16851077},{"date":"2023-08-18","current":-0.489643,"twenty":-2.455927,"median":-1.364313,"eighty":-0.677154,"marketCap":15584811},{"date":"2023-08-25","current":-0.547788,"twenty":-2.455927,"median":-1.364313,"eighty":-0.671183,"marketCap":17435507},{"date":"2023-09-01","current":-0.541668,"twenty":-2.455927,"median":-1.364313,"eighty":-0.670283,"marketCap":17240697},{"date":"2023-09-08","current":-0.703862,"twenty":-2.455927,"median":-1.364313,"eighty":-0.670283,"marketCap":22403166},{"date":"2023-09-15","current":-0.621235,"twenty":-2.455927,"median":-1.364313,"eighty":-0.67029,"marketCap":19773229},{"date":"2023-09-22","current":-0.670199,"twenty":-2.455927,"median":-1.364313,"eighty":-0.670283,"marketCap":21331710},{"date":"2023-09-29","current":-0.791504,"twenty":-2.455927,"median":-1.364313,"eighty":-0.670283,"marketCap":25192695},{"date":"2023-10-06","current":-0.890343,"twenty":-2.455927,"median":-1.364313,"eighty":-0.670283,"marketCap":28338644},{"date":"2023-10-13","current":-0.840359,"twenty":-2.455927,"median":-1.364313,"eighty":-0.67029,"marketCap":26747702},{"date":"2023-10-20","current":-0.821615,"twenty":-2.455927,"median":-1.364313,"eighty":-0.67029,"marketCap":26151099},{"date":"2023-10-27","current":-0.765383,"twenty":-2.455927,"median":-1.371024,"eighty":-0.671484,"marketCap":24361290},{"date":"2023-11-03","current":-0.749763,"twenty":-2.455927,"median":-1.371024,"eighty":-0.677154,"marketCap":23864121},{"date":"2023-11-10","current":-0.609182,"twenty":-2.455927,"median":-1.371024,"eighty":-0.680681,"marketCap":19389598},{"date":"2023-11-17","current":-0.526803,"twenty":-2.455927,"median":-1.371024,"eighty":-0.67632,"marketCap":19886768},{"date":"2023-11-24","current":-0.68359,"twenty":-2.455927,"median":-1.371024,"eighty":-0.67632,"marketCap":25805482},{"date":"2023-12-01","current":-0.804032,"twenty":-2.455927,"median":-1.371024,"eighty":-0.67632,"marketCap":30352162},{"date":"2023-12-08","current":-0.817053,"twenty":-2.455927,"median":-1.368092,"eighty":-0.676472,"marketCap":30843695},{"date":"2023-12-15","current":-0.862626,"twenty":-2.455927,"median":-1.368092,"eighty":-0.676472,"marketCap":32564061},{"date":"2023-12-22","current":-0.859371,"twenty":-2.455927,"median":-1.368092,"eighty":-0.677154,"marketCap":32441178},{"date":"2023-12-29","current":-0.810543,"twenty":-2.459512,"median":-1.371066,"eighty":-0.68359,"marketCap":30597929},{"date":"2024-01-05","current":-0.921219,"twenty":-2.463098,"median":-1.371108,"eighty":-0.684208,"marketCap":34775959},{"date":"2024-01-12","current":-1.119786,"twenty":-2.463098,"median":-1.371108,"eighty":-0.687735,"marketCap":42271838},{"date":"2024-01-19","current":-1.152338,"twenty":-2.466683,"median":-1.371634,"eighty":-0.695517,"marketCap":43500670},{"date":"2024-01-26","current":-1.168614,"twenty":-2.463098,"median":-1.371108,"eighty":-0.696611,"marketCap":44115086},{"date":"2024-02-02","current":-3.170245,"twenty":-2.47556,"median":-1.37216,"eighty":-0.698541,"marketCap":119676525},{"date":"2024-02-09","current":-2.83144,"twenty":-2.511321,"median":-1.382521,"eighty":-0.705287,"marketCap":106886667},{"date":"2024-02-16","current":-2.895974,"twenty":-2.559581,"median":-1.389315,"eighty":-0.71595,"marketCap":109322830},{"date":"2024-02-23","current":-2.702372,"twenty":-2.602292,"median":-1.395777,"eighty":-0.722058,"marketCap":102014340},{"date":"2024-03-01","current":-3.162178,"twenty":-2.640716,"median":-1.403441,"eighty":-0.725922,"marketCap":119372004},{"date":"2024-03-08","current":-3.28318,"twenty":-2.654096,"median":-1.410827,"eighty":-0.740082,"marketCap":123939810},{"date":"2024-03-15","current":-2.726572,"twenty":-2.68046,"median":-1.424856,"eighty":-0.740082,"marketCap":102927901},{"date":"2024-03-22","current":-3.121844,"twenty":-2.705602,"median":-1.438947,"eighty":-0.740082,"marketCap":117849402},{"date":"2024-03-28","current":-2.914244,"twenty":-2.737044,"median":-1.450802,"eighty":-0.740082,"marketCap":110693172},{"date":"2024-04-05","current":-3.159506,"twenty":-2.768117,"median":-1.453935,"eighty":-0.738597,"marketCap":120009097},{"date":"2024-04-12","current":-3.151013,"twenty":-2.795029,"median":-1.457678,"eighty":-0.738597,"marketCap":119686492},{"date":"2024-04-19","current":-2.581962,"twenty":-2.80756,"median":-1.464554,"eighty":-0.738597,"marketCap":98071950},{"date":"2024-04-26","current":-2.564976,"twenty":-2.8074,"median":-1.472805,"eighty":-0.740082,"marketCap":97426740},{"date":"2024-05-03","current":-3.152301,"twenty":-2.818244,"median":-1.479044,"eighty":-0.740082,"marketCap":119735406},{"date":"2024-05-10","current":-3.057921,"twenty":-2.825242,"median":-1.48319,"eighty":-0.740082,"marketCap":116150513},{"date":"2024-05-17","current":-2.341465,"twenty":-2.840499,"median":-1.488219,"eighty":-0.740082,"marketCap":119376916},{"date":"2024-05-24","current":-2.151616,"twenty":-2.840499,"median":-1.492706,"eighty":-0.740082,"marketCap":109697707},{"date":"2024-05-31","current":-2.137553,"twenty":-2.840499,"median":-1.493972,"eighty":-0.740082,"marketCap":108980728},{"date":"2024-06-07","current":-2.130522,"twenty":-2.840499,"median":-1.493972,"eighty":-0.740082,"marketCap":108622239},{"date":"2024-06-14","current":-2.362559,"twenty":-2.842268,"median":-1.495239,"eighty":-0.738597,"marketCap":120452384},{"date":"2024-06-21","current":-1.968799,"twenty":-2.844036,"median":-1.493972,"eighty":-0.737113,"marketCap":100376987},{"date":"2024-06-28","current":-1.638322,"twenty":-2.848813,"median":-1.495239,"eighty":-0.734086,"marketCap":83527992},{"date":"2024-07-05","current":-1.736762,"twenty":-2.848813,"median":-1.495239,"eighty":-0.734086,"marketCap":88546842},{"date":"2024-07-12","current":-1.736762,"twenty":-2.848813,"median":-1.502259,"eighty":-0.734086,"marketCap":88546842},{"date":"2024-07-15","current":-1.778951,"twenty":-2.848813,"median":-1.502259,"eighty":-0.734086,"marketCap":90697777},{"date":"2024-08-02","current":-1.448474,"twenty":-2.858906,"median":-1.499353,"eighty":-0.726559,"marketCap":73848783},{"date":"2024-08-09","current":-1.357065,"twenty":-2.858906,"median":-1.492382,"eighty":-0.726559,"marketCap":69188423},{"date":"2024-08-16","current":-1.427379,"twenty":-2.858906,"median":-1.489129,"eighty":-0.726559,"marketCap":72773315},{"date":"2024-08-23","current":-1.469568,"twenty":-2.858906,"median":-1.486189,"eighty":-0.726559,"marketCap":74924251},{"date":"2024-08-30","current":-1.539882,"twenty":-2.858906,"median":-1.496239,"eighty":-0.726559,"marketCap":78509143},{"date":"2024-09-06","current":-1.476599,"twenty":-2.858906,"median":-1.504725,"eighty":-0.726559,"marketCap":75282740},{"date":"2024-09-13","current":-1.483631,"twenty":-2.858906,"median":-1.492706,"eighty":-0.726559,"marketCap":75641229},{"date":"2024-09-20","current":-1.483631,"twenty":-2.858906,"median":-1.488453,"eighty":-0.726559,"marketCap":75641229},{"date":"2024-09-27","current":-1.343002,"twenty":-2.858906,"median":-1.483631,"eighty":-0.726559,"marketCap":68471444},{"date":"2024-10-04","current":-1.518788,"twenty":-2.858906,"median":-1.488453,"eighty":-0.726559,"marketCap":77433675},{"date":"2024-10-11","current":-1.476599,"twenty":-2.858906,"median":-1.49236,"eighty":-0.726559,"marketCap":75282740},{"date":"2024-10-18","current":-1.448474,"twenty":-2.858906,"median":-1.49236,"eighty":-0.726559,"marketCap":73848783},{"date":"2024-10-25","current":-1.476599,"twenty":-2.858906,"median":-1.49236,"eighty":-0.726559,"marketCap":75282740},{"date":"2024-10-31","current":-1.525463,"twenty":-2.858906,"median":-1.4952,"eighty":-0.726559,"marketCap":73490294},{"date":"2024-11-08","current":-1.57011,"twenty":-2.859722,"median":-1.504725,"eighty":-0.725908,"marketCap":75641229},{"date":"2024-11-15","current":-1.360507,"twenty":-2.859722,"median":-1.504725,"eighty":-0.734143,"marketCap":72056337},{"date":"2024-11-22","current":-1.27916,"twenty":-2.859722,"median":-1.504725,"eighty":-0.743515,"marketCap":64095123},{"date":"2024-11-29","current":-1.268391,"twenty":-2.859722,"median":-1.504725,"eighty":-0.743515,"marketCap":63555538},{"date":"2024-12-06","current":-1.120138,"twenty":-2.859722,"median":-1.504725,"eighty":-0.743515,"marketCap":56126968},{"date":"2024-12-13","current":-0.217439,"twenty":-2.859722,"median":-1.504725,"eighty":-0.734143,"marketCap":10895235},{"date":"2024-12-20","current":-0.196024,"twenty":-2.859722,"median":-1.504725,"eighty":-0.707279,"marketCap":9822219},{"date":"2024-12-27","current":-0.25269,"twenty":-2.859722,"median":-1.504725,"eighty":-0.696611,"marketCap":12661583},{"date":"2025-01-03","current":-0.267598,"twenty":-2.859722,"median":-1.499772,"eighty":-0.678312,"marketCap":13408567},{"date":"2025-01-10","current":-0.256149,"twenty":-2.860519,"median":-1.4952,"eighty":-0.672905,"marketCap":12834917},{"date":"2025-01-17","current":-0.199483,"twenty":-2.860519,"median":-1.490662,"eighty":-0.663943,"marketCap":9995552},{"date":"2025-01-24","current":-0.200884,"twenty":-2.860519,"median":-1.483631,"eighty":-0.656377,"marketCap":10065711},{"date":"2025-01-31","current":-0.205084,"twenty":-2.860519,"median":-1.476599,"eighty":-0.653085,"marketCap":10276187},{"date":"2025-02-07","current":-0.227322,"twenty":-2.860519,"median":-1.469568,"eighty":-0.649765,"marketCap":11390473},{"date":"2025-02-14","current":-0.258415,"twenty":-2.860519,"median":-1.462536,"eighty":-0.649371,"marketCap":12948445},{"date":"2025-02-21","current":-0.307523,"twenty":-2.860519,"median":-1.455889,"eighty":-0.646211,"marketCap":15409110},{"date":"2025-02-28","current":-0.264392,"twenty":-2.860519,"median":-1.455557,"eighty":-0.642751,"marketCap":13247964},{"date":"2025-03-07","current":-0.281773,"twenty":-2.861316,"median":-1.455505,"eighty":-0.637961,"marketCap":14118874},{"date":"2025-03-14","current":-0.30967,"twenty":-2.861316,"median":-1.455505,"eighty":-0.627475,"marketCap":13805530},{"date":"2025-03-21","current":-0.392876,"twenty":-2.861316,"median":-1.455505,"eighty":-0.621802,"marketCap":17514960},{"date":"2025-03-28","current":-0.372307,"twenty":-2.861316,"median":-1.455505,"eighty":-0.618851,"marketCap":16597970},{"date":"2025-04-04","current":-0.303055,"twenty":-2.861316,"median":-1.455505,"eighty":-0.611866,"marketCap":13510619},{"date":"2025-04-11","current":-0.281969,"twenty":-2.860519,"median":-1.452002,"eighty":-0.605839,"marketCap":12570589},{"date":"2025-04-17","current":-0.292719,"twenty":-2.860519,"median":-1.452002,"eighty":-0.600469,"marketCap":13049820},{"date":"2025-04-25","current":-0.323417,"twenty":-2.861316,"median":-1.455505,"eighty":-0.592686,"marketCap":14418392},{"date":"2025-05-02","current":-0.27308,"twenty":-2.861316,"median":-1.455505,"eighty":-0.58434,"marketCap":12174302},{"date":"2025-05-09","current":-0.259953,"twenty":-2.861316,"median":-1.455505,"eighty":-0.579875,"marketCap":11589088},{"date":"2025-05-16","current":-0.476316,"twenty":-2.861316,"median":-1.455505,"eighty":-0.57508,"marketCap":11690464},{"date":"2025-05-23","current":-0.473125,"twenty":-2.861316,"median":-1.455505,"eighty":-0.567153,"marketCap":11612128},{"date":"2025-05-30","current":-0.495654,"twenty":-2.861316,"median":-1.455505,"eighty":-0.564172,"marketCap":12165087},{"date":"2025-06-06","current":-0.766199,"twenty":-2.861316,"median":-1.448474,"eighty":-0.561109,"marketCap":18805196},{"date":"2025-06-13","current":-0.820458,"twenty":-2.861316,"median":-1.434963,"eighty":-0.561109,"marketCap":20136905},{"date":"2025-06-20","current":-0.686218,"twenty":-2.862113,"median":-1.434411,"eighty":-0.560832,"marketCap":16842194},{"date":"2025-06-27","current":-0.544863,"twenty":-2.862113,"median":-1.427379,"eighty":-0.560279,"marketCap":13372840},{"date":"2025-07-03","current":-0.354382,"twenty":-2.862113,"median":-1.415815,"eighty":-0.559226,"marketCap":8697782},{"date":"2025-07-11","current":-0.36398,"twenty":-2.862113,"median":-1.406445,"eighty":-0.554197,"marketCap":8933347},{"date":"2025-07-18","current":-0.578544,"twenty":-2.862113,"median":-1.392222,"eighty":-0.551409,"marketCap":14199478},{"date":"2025-07-25","current":-0.622778,"twenty":-2.862113,"median":-1.37818,"eighty":-0.551409,"marketCap":15285153},{"date":"2025-08-01","current":-0.563411,"twenty":-2.862113,"median":-1.370772,"eighty":-0.55032,"marketCap":13828063},{"date":"2025-08-08","current":-0.548278,"twenty":-2.862113,"median":-1.356102,"eighty":-0.549652,"marketCap":13456648},{"date":"2025-08-15","current":-0.485305,"twenty":-2.862113,"median":-1.344156,"eighty":-0.548278,"marketCap":14108816},{"date":"2025-08-22","current":-0.492991,"twenty":-2.862113,"median":-1.329467,"eighty":-0.5438,"marketCap":14332259},{"date":"2025-08-29","current":-0.514951,"twenty":-2.862113,"median":-1.314652,"eighty":-0.542135,"marketCap":14970667},{"date":"2025-09-05","current":-0.546792,"twenty":-2.86291,"median":-1.30524,"eighty":-0.539697,"marketCap":15896359},{"date":"2025-09-12","current":-0.579731,"twenty":-2.862113,"median":-1.284536,"eighty":-0.539697,"marketCap":16853971},{"date":"2025-09-19","current":-0.602789,"twenty":-2.862113,"median":-1.278581,"eighty":-0.539697,"marketCap":17524299},{"date":"2025-09-26","current":-0.631336,"twenty":-2.862113,"median":-1.269728,"eighty":-0.539697,"marketCap":18354230},{"date":"2025-10-03","current":-0.636826,"twenty":-2.862113,"median":-1.261912,"eighty":-0.539697,"marketCap":18513832},{"date":"2025-10-10","current":-0.523735,"twenty":-2.862113,"median":-1.245054,"eighty":-0.538608,"marketCap":15226030},{"date":"2025-10-17","current":-0.521539,"twenty":-2.862113,"median":-1.210068,"eighty":-0.538088,"marketCap":15162190},{"date":"2025-10-24","current":-0.415035,"twenty":-2.862113,"median":-1.192478,"eighty":-0.536386,"marketCap":12065911},{"date":"2025-10-31","current":-0.35794,"twenty":-2.862113,"median":-1.167076,"eighty":-0.534695,"marketCap":10406050},{"date":"2025-11-07","current":-0.376606,"twenty":-2.862113,"median":-1.150447,"eighty":-0.531595,"marketCap":10948697},{"date":"2025-11-14","current":-0.315119,"twenty":-2.862113,"median":-1.138828,"eighty":-0.528413,"marketCap":9161154},{"date":"2025-11-21","current":-0.634293,"twenty":-2.862113,"median":-1.127224,"eighty":-0.52694,"marketCap":11957177},{"date":"2025-11-28","current":-0.807487,"twenty":-2.862113,"median":-1.120099,"eighty":-0.52694,"marketCap":15222081},{"date":"2025-12-05","current":-0.854721,"twenty":-2.85129,"median":-1.109333,"eighty":-0.52694,"marketCap":16112509},{"date":"2025-12-12","current":-0.850223,"twenty":-2.823373,"median":-1.100993,"eighty":-0.52694,"marketCap":16027706},{"date":"2025-12-19","current":-0.609551,"twenty":-2.814978,"median":-1.081228,"eighty":-0.52694,"marketCap":11490763},{"date":"2025-12-26","current":-0.620797,"twenty":-2.805842,"median":-1.065406,"eighty":-0.52694,"marketCap":11702769},{"date":"2026-01-02","current":-0.663533,"twenty":-2.792758,"median":-1.056217,"eighty":-0.52694,"marketCap":12508395},{"date":"2026-01-09","current":-0.744507,"twenty":-2.75581,"median":-1.047962,"eighty":-0.52694,"marketCap":14034843},{"date":"2026-01-16","current":-0.820982,"twenty":-2.721585,"median":-1.029047,"eighty":-0.52694,"marketCap":15476489},{"date":"2026-01-23","current":-0.85697,"twenty":-2.702372,"median":-1.013967,"eighty":-0.52694,"marketCap":16154910},{"date":"2026-01-30","current":-0.728762,"twenty":-2.669266,"median":-0.996329,"eighty":-0.52694,"marketCap":13738034},{"date":"2026-02-06","current":-0.634293,"twenty":-2.645451,"median":-0.960674,"eighty":-0.52694,"marketCap":11957177},{"date":"2026-02-13","current":-0.70627,"twenty":-2.633205,"median":-0.924507,"eighty":-0.52694,"marketCap":13314020},{"date":"2026-02-20","current":-0.767,"twenty":-2.603613,"median":-0.920946,"eighty":-0.52694,"marketCap":14458856},{"date":"2026-02-27","current":-0.789492,"twenty":-2.561776,"median":-0.907752,"eighty":-0.52694,"marketCap":14882870},{"date":"2026-03-06","current":-0.538991,"twenty":-2.423122,"median":-0.89746,"eighty":-0.52694,"marketCap":11745171},{"date":"2026-03-13","current":-0.628498,"twenty":-2.34795,"median":-0.889406,"eighty":-0.52694,"marketCap":13695616},{"date":"2026-03-20","current":-0.618769,"twenty":-2.314745,"median":-0.867654,"eighty":-0.52694,"marketCap":13483610},{"date":"2026-03-27","current":-0.564286,"twenty":-2.240234,"median":-0.862626,"eighty":-0.52694,"marketCap":12296374},{"date":"2026-04-02","current":-0.486453,"twenty":-2.186773,"median":-0.855846,"eighty":-0.524871,"marketCap":10600322},{"date":"2026-04-10","current":-0.548719,"twenty":-2.145243,"median":-0.851347,"eighty":-0.524833,"marketCap":11957163},{"date":"2026-04-17","current":-0.58569,"twenty":-2.092667,"median":-0.841355,"eighty":-0.524833,"marketCap":12762788},{"date":"2026-04-24","current":-0.541909,"twenty":-2.043332,"median":-0.836584,"eighty":-0.524833,"marketCap":11808759},{"date":"2026-05-01","current":-0.505911,"twenty":-2.00492,"median":-0.828921,"eighty":-0.523478,"marketCap":11024335},{"date":"2026-05-08","current":-0.642118,"twenty":-1.965371,"median":-0.82214,"eighty":-0.523353,"marketCap":13992425},{"date":"2026-05-15","current":-0.62266,"twenty":-1.960228,"median":-0.820596,"eighty":-0.523353,"marketCap":13568412},{"date":"2026-05-22","current":-1.215589,"twenty":-1.943594,"median":-0.819474,"eighty":-0.523353,"marketCap":25334044},{"date":"2026-05-29","current":-1.204085,"twenty":-1.928976,"median":-0.818491,"eighty":-0.52333,"marketCap":25094289},{"date":"2026-06-05","current":-1.054533,"twenty":-1.871769,"median":-0.819474,"eighty":-0.523353,"marketCap":21977483},{"date":"2026-06-12","current":-0.8628,"twenty":-1.83651,"median":-0.819474,"eighty":-0.523353,"marketCap":17981577},{"date":"2026-06-18","current":-0.950997,"twenty":-1.814891,"median":-0.819474,"eighty":-0.523353,"marketCap":19819693},{"date":"2026-06-26","current":-0.947163,"twenty":-1.746838,"median":-0.818491,"eighty":-0.52333,"marketCap":19739775},{"date":"2026-07-02","current":-1.085211,"twenty":-1.736762,"median":-0.818491,"eighty":-0.52333,"marketCap":22616827},{"date":"2026-07-10","current":-1.062203,"twenty":-1.706407,"median":-0.818491,"eighty":-0.52333,"marketCap":22137319},{"date":"2026-07-17","current":-0.989344,"twenty":-1.679075,"median":-0.818491,"eighty":-0.52333,"marketCap":20618874},{"date":"2026-07-24","current":-0.947163,"twenty":-1.659249,"median":-0.818491,"eighty":-0.52333,"marketCap":19739775},{"date":"2026-07-31","current":-0.970171,"twenty":-1.649392,"median":-0.817772,"eighty":-0.523306,"marketCap":20219284},{"date":"2026-08-07","current":-0.966336,"twenty":-1.601598,"median":-0.817772,"eighty":-0.523306,"marketCap":20139366},{"date":"2026-08-14","current":-0.887832,"twenty":-1.595906,"median":-0.817772,"eighty":-0.523306,"marketCap":19819693},{"date":"2026-08-21","current":-1.096636,"twenty":-1.572722,"median":-0.817772,"eighty":-0.523306,"marketCap":24480959},{"date":"2026-08-28","current":-1.075465,"twenty":-1.546914,"median":-0.817772,"eighty":-0.523306,"marketCap":24008354},{"date":"2026-09-01","current":-1.062763,"twenty":-1.540345,"median":-0.817772,"eighty":-0.523306,"marketCap":23724791}],"updateTime":1788349907942},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CLRB\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2635713719","title":"Cellectar Biosciences Q1 EPS $(1.33) Beats $(1.89) Estimate. Cash And Equivalents $8.35M","url":"https://stock-news.laohu8.com/highlight/detail?id=2635713719","media":"Benzinga Earnings","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635713719?lang=en_us&edition=fundamental","pubTime":"2026-05-14 19:08","pubTimestamp":1778756892,"startTime":"0","endTime":"0","summary":"Cellectar Biosciences (NASDAQ:CLRB) reported quarterly losses of $(1.33) per share which beat the analyst consensus estimate of $(1.89) by 29.26 percent. This is a 69.07 percent increase over losses of $(4.30) per share","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/05/52554683/cellectar-biosciences-q1-eps-1-33-beats-1-89-estimate-cash-and-equivalents-8-35m","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CLRB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635199997","title":"Cellectar net loss narrows 12% to $5.7 million in Q1 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2635199997","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635199997?lang=en_us&edition=fundamental","pubTime":"2026-05-14 19:03","pubTimestamp":1778756580,"startTime":"0","endTime":"0","summary":"Cellectar BioSciences posted a net loss of about $5.7 million for three months ended March 31, 2026, using about $4.8 million in cash for operations.Research and development expense fell 12% to about $3.01 million, reflecting lower clinical project costs following completion of enrollment in Waldenstrom macroglobulinemia patients.General and administrative expense slipped 6% to about $2.79 million, while other income turned positive to about $140,000 on warrant-valuation changes.Cash balance was about $8.3 million at quarter-end, with available liquidity cited at about $37 million beyond the financial statement issuance date; absent added liquidity, funding under normal course may not extend beyond second quarter of 2027.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260514:nNDL8XPR4m:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CLRB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634103712","title":"Cellectar Biosciences Inc  expected to post a loss of $1.88 a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2634103712","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634103712?lang=en_us&edition=fundamental","pubTime":"2026-05-12 22:04","pubTimestamp":1778594644,"startTime":"0","endTime":"0","summary":"Cellectar Biosciences Inc  expected to post a loss of $1.88 a share - Earnings Preview Cellectar Biosciences Inc CLRB.OQ CLRB.O is expected to  show no change in quarterly revenue when it reports  res","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260512:nL8N41P24X:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CLRB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634259232","title":"Cellectar COO Jarrod Longcor acquires 8,680 shares for $24,998.4","url":"https://stock-news.laohu8.com/highlight/detail?id=2634259232","media":"Reuters","labels":["insiderTrades","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634259232?lang=en_us&edition=fundamental","pubTime":"2026-05-12 08:07","pubTimestamp":1778544474,"startTime":"0","endTime":"0","summary":"Jarrod Longcor, Chief Operating Officer, bought 8,680 Cellectar Biosciences common shares at USD 2.88.Also bought 26,040 warrants with an exercise price of USD 2.88, paying USD 0.01 per warrant.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cellectar BioSciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 11, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260512:nNDLb1NvPV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Cellectar COO Jarrod Longcor acquires 8,680 shares for $24,998.4","news_tag":"insiderTrades,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CLRB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634592532","title":"Cellectar CEO James Caruso acquires 8,680 shares worth $24,998.4","url":"https://stock-news.laohu8.com/highlight/detail?id=2634592532","media":"Reuters","labels":["shareholding","insiderTrades","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634592532?lang=en_us&edition=fundamental","pubTime":"2026-05-12 08:06","pubTimestamp":1778544387,"startTime":"0","endTime":"0","summary":"Cellectar BioSciences CEO James V. Caruso bought 8,680 common shares at USD 2.88, lifting his direct holding to 20,318 shares.Caruso also bought 26,040 warrants with an exercise price of USD 2.88, increasing his warrant position to 36,076.Warrants were priced at USD 0.01 per warrant.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cellectar BioSciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 11, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260512:nNDL30NPqg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,insiderTrades,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CLRB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634867072","title":"Cellectar Biosciences schedules first-quarter results conference call and webcast","url":"https://stock-news.laohu8.com/highlight/detail?id=2634867072","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634867072?lang=en_us&edition=fundamental","pubTime":"2026-05-11 20:07","pubTimestamp":1778501265,"startTime":"0","endTime":"0","summary":"Cellectar Biosciences schedules first-quarter 2026 results release, corporate update, conference call for May 14, 2026 at 8:30 a.m. ET.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cellectar BioSciences Inc. published the original content used to generate this news brief on May 11, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260511:nNDL7xL7dl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CLRB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634289402","title":"Cellectar Biosciences to Report First Quarter Financial Results and Host a Conference Call on Thursday, May 14, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2634289402","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634289402?lang=en_us&edition=fundamental","pubTime":"2026-05-11 20:05","pubTimestamp":1778501100,"startTime":"0","endTime":"0","summary":"FLORHAM PARK, N.J., May  11, 2026 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery and development of drugs for ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/11/3291850/29076/en/Cellectar-Biosciences-to-Report-First-Quarter-Financial-Results-and-Host-a-Conference-Call-on-Thursday-May-14-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1585245621.USD","LU2089279066.USD","LU2092937221.SGD","LU1803068623.USD","LU2125910179.SGD","BK4120","LU2362540622.SGD","BK4588","LU1430594728.SGD","LU1923621640.USD","LU2028103732.USD","LU2041044095.USD","LU1623119135.USD","BK4534","BK4566","BK4533","BK4585","CNS","LU0069063385.USD","LU0472753341.HKD","LU2355687059.USD","WM","BK4123","LU1892829315.USD","LU2229751404.USD","LU1721428933.USD","LU2362541513.USD","LU2463526074.USD","LU0094547139.USD","LU2413666426.HKD","LU2089284900.SGD","LU2023250504.SGD","BK4135","PDC","LU0124676726.USD","LU0289961442.SGD","BK4181","LU0347712357.USD","LU2362541273.HKD","BK4218","LU1989772923.USD","LU0175139822.USD","LU0289960550.SGD","LU1974910355.USD","LU1917777945.USD","LU0158827948.USD","LU2271345857.HKD","CLRB","LU2106854487.HKD","HST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633468596","title":"Cellectar Biosciences Inc  expected to post a loss of $1.88 a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2633468596","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633468596?lang=en_us&edition=fundamental","pubTime":"2026-05-08 23:31","pubTimestamp":1778254270,"startTime":"0","endTime":"0","summary":"Cellectar Biosciences Inc  expected to post a loss of $1.88 a share - Earnings Preview Cellectar Biosciences Inc CLRB.OQ CLRB.O is expected to  show no change in quarterly revenue when it reports  res","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260508:nL8N41L1VM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CLRB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633434760","title":"Cellectar BioSciences sells 2,116,887 unregistered shares in private placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2633434760","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633434760?lang=en_us&edition=fundamental","pubTime":"2026-05-08 18:10","pubTimestamp":1778235024,"startTime":"0","endTime":"0","summary":"Cellectar BioSciences entered a concurrent private placement on May 4, 2026, alongside a registered direct offering.Private placement covers 2,116,887 unregistered common shares, pre-funded warrants for 9,471,086 shares, and 13,206,026 milestone-based warrants in each of Tranche A, Tranche B, Tranche C.Milestone warrants require stockholder approval to become exercisable, carry a $2.65 exercise price, and run for 1 year, 2 years, and 5 years, respectively.Call feature requires common stock to trade above 130% of exercise price for 20 straight sessions, with average daily volume of at least $500,000.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cellectar BioSciences Inc. published the original content used to generate this news brief ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260508:nNDL8Hn6B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CLRB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633416569","title":"Cellectar Biosciences price target lowered to $11 from $14 at Roth Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2633416569","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633416569?lang=en_us&edition=fundamental","pubTime":"2026-05-05 22:55","pubTimestamp":1777992941,"startTime":"0","endTime":"0","summary":"Roth Capital analyst Jonathan Aschoff lowered the firm’s price target on Cellectar Biosciences (CLRB) to $11 from $14 and keeps a Buy rating on the...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cellectar-biosciences-price-target-lowered-to-11-from-14-at-roth-capital-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cellectar-biosciences-price-target-lowered-to-11-from-14-at-roth-capital-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CLRB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633126759","title":"Cellectar says iopofosine I 131 posts 61.8% major response rate in Phase 2b WM trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2633126759","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633126759?lang=en_us&edition=fundamental","pubTime":"2026-05-05 19:16","pubTimestamp":1777979816,"startTime":"0","endTime":"0","summary":"Cellectar BioSciences reported updated 12-month follow-up results from Phase 2b CLOVER WaM study of iopofosine I 131 in relapsed or refractory Waldenstrm macroglobulinemia, with responses remaining durable and consistent in heavily pretreated patients.Dataset was compiled to meet an FDA request for at least 12 months of follow-up on all patients, strengthening positioning for an accelerated approval filing.Post-BTK inhibitor subgroups showed sustained benefit, supporting a potential role in later-line treatment where options are limited.Efficacy and safety results in patients treated immediately following BTK inhibitor therapy will be presented at ASCO meeting running May 29-June 2, 2026.Recently announced oversubscribed financing of up to USD 140 million is expected to fund confirmatory trial start in 4Q26, supporting an NDA submission strategy tied to accelerated approval.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260505:nNDL7cJBR2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2095319765.USD","BK4585","IE00BGHQF748.EUR","BK4588","CLRB","IE00B64PRP62.GBP","LU2210150020.SGD","SG9999014039.USD","IE00BKPKM429.USD","LU0314104364.USD","IE00BN0W2T93.GBP","BK4139","SG9999014021.USD","BK4112","NDAQ","SG9999014005.SGD","IE00B3QW5Z07.USD","IE00BN0W2W23.USD","IE00BN0W2V16.EUR","SG9999014013.SGD","LU2210149790.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633912867","title":"Cellectar BioSciences prices private placement of shares and warrants at up to $140 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2633912867","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633912867?lang=en_us&edition=fundamental","pubTime":"2026-05-05 19:10","pubTimestamp":1777979422,"startTime":"0","endTime":"0","summary":"Cellectar BioSciences entered securities purchase agreements for financing of up to USD 140 million, including a concurrent private placement in an unregistered sale.Private placement covers 2,116,887 common shares, pre-funded warrants for 9,471,086 shares, and 13,206,026 each of milestone-based Tranche A, Tranche B, Tranche C warrants; milestone warrants carry USD 2.65 exercise price.Company expects USD 35 million upfront, with up to USD 105 million tied to milestone-based securities; proceeds earmarked for confirmatory study, NDA filing plans for iopofosine I 131 in Waldenstrm macroglobulinemia.Management also agreed to buy common stock at USD 2.88 per share with accompanying milestone-based warrants at USD 2.88 exercise price.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260505:nNDLb7Ck9v:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BN0W2T93.GBP","CLRB","SG9999014013.SGD","SG9999014021.USD","LU0314104364.USD","IE00BKPKM429.USD","LU2210150020.SGD","IE00BN0W2V16.EUR","SG9999014039.USD","SG9999014005.SGD","BK4139","IE00BGHQF748.EUR","BK4112","LU2095319765.USD","BK4585","IE00BN0W2W23.USD","IE00B64PRP62.GBP","NDAQ","BK4588","IE00B3QW5Z07.USD","LU2210149790.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633912859","title":"Cellectar Biosciences Inc - Reports 83.6% Orr, 61.8% Mrr, Median Duration of Response 17.8 Months in Phase 2B Clover Wam","url":"https://stock-news.laohu8.com/highlight/detail?id=2633912859","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633912859?lang=en_us&edition=fundamental","pubTime":"2026-05-05 19:10","pubTimestamp":1777979400,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260505:nTUA84H1QV:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","CLRB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633912850","title":"Cellectar Biosciences Reports Positive 12-Month Follow-up Data From Phase 2B Clover Wam Study Demonstrating Durable Responses and Efficacy of Iopofosine I 131 in R/R WaldenstrÖM Macroglobulinemia","url":"https://stock-news.laohu8.com/highlight/detail?id=2633912850","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633912850?lang=en_us&edition=fundamental","pubTime":"2026-05-05 19:10","pubTimestamp":1777979400,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260505:nTUA84H1QV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CLRB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633852912","title":"Cellectar Biosciences: Advancing Plans to Initiate a Confirmatory Randomized Study in a Post-First Line, Post-Btki Population","url":"https://stock-news.laohu8.com/highlight/detail?id=2633852912","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633852912?lang=en_us&edition=fundamental","pubTime":"2026-05-05 19:10","pubTimestamp":1777979400,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260505:nTUA84H1QV:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","CLRB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633408912","title":"Cellectar Biosciences Reports Positive 12-Month Follow-Up Data from Phase 2b CLOVER WaM Study Demonstrating Durable Responses and Efficacy of Iopofosine I 131 in r/r Waldenström Macroglobulinemia","url":"https://stock-news.laohu8.com/highlight/detail?id=2633408912","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633408912?lang=en_us&edition=fundamental","pubTime":"2026-05-05 19:10","pubTimestamp":1777979400,"startTime":"0","endTime":"0","summary":"83.6% ORR and 61.8% MRR achieved in heavily pretreated population with median duration of response of 17.8 months FDA-requested dataset with ≥12-month follow-up on all patients strengthens regulatory ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/05/3287522/29076/en/Cellectar-Biosciences-Reports-Positive-12-Month-Follow-Up-Data-from-Phase-2b-CLOVER-WaM-Study-Demonstrating-Durable-Responses-and-Efficacy-of-Iopofosine-I-131-in-r-r-Waldenstr%C3%B6m-Ma.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CLRB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633591425","title":"Cellectar Biosciences Inc - Financing Led by Nantahala Capital With Participation From Major Healthcare Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2633591425","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633591425?lang=en_us&edition=fundamental","pubTime":"2026-05-05 19:00","pubTimestamp":1777978800,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260505:nTUAC9ZGCN:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CLRB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633145449","title":"Press Release: Cellectar Biosciences Announces Oversubscribed Financing Up to $140 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2633145449","media":"Dow Jones","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633145449?lang=en_us&edition=fundamental","pubTime":"2026-05-05 19:00","pubTimestamp":1777978800,"startTime":"0","endTime":"0","summary":"Oversubscribed Financing Led by Nantahala Capital with Participation from Balyasny Asset Management, Caligan Partners, Janus Henderson Investors, SilverArc Capital Management, Stonepine Capital Management, Empery Asset Management LP, StemPoint Capital LP and other Dedicated Healthcare Funds along with Members of the Executive Management Team. Financing of up to $140 Million Supports Confirmatory Study and NDA Filing for Accelerated Approval of Iopofosine I 131 in Waldenstrm Macroglobulinemia with the FDA. Andrew Gu of Nantahala Capital Management, LLC to Join the Company's Board of Directors Upon Closing. FLORHAM PARK, N.J., May 05, 2026  --  Cellectar Biosciences, Inc. , a late-stage clinical biopharmaceutical company focused on the discovery and development of targeted oncology therapies, today announced that it has entered into a securities purchase agreement with certain institutional investors, and an additional securities purchase agreement with certain members of management, to ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2125910336.SGD","LU1917777945.USD","BK4120","BK4585","LU0158827781.USD","LU0069063385.USD","PDC","LU2362540622.SGD","LU2238339852.HKD","LU2111349929.HKD","LU2106854487.HKD","LU0347712357.USD","03160","LU0289960550.SGD","LU1989772840.SGD","LU1923621640.USD","LU1989772923.USD","LU2229751404.USD","BK4533","LU2463526074.USD","BK4555","LU0158827948.USD","LU2413666699.HKD","LU2413666426.HKD","BK4135","LU1712237335.SGD","LU2089284900.SGD","BK4534","LU2023250504.SGD","TM","LU0472753341.HKD","LU1623119135.USD","LU1939255532.USD","LU2355687059.USD","BK4588","LU0175139822.USD","LU0124676726.USD","BK4566","CLRB","BK4099","LU2240825500.USD","WM","BK4604","LU0094547139.USD","LU2023250843.SGD","LU2089283258.USD","LU2362541513.USD","CNS","LU2125910179.SGD","LU0511384066.AUD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629374560","title":"Cellectar CLOVER-WaM trial data accepted for ASCO 2026 poster presentation","url":"https://stock-news.laohu8.com/highlight/detail?id=2629374560","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629374560?lang=en_us&edition=fundamental","pubTime":"2026-04-21 22:01","pubTimestamp":1776780102,"startTime":"0","endTime":"0","summary":"Cellectar Biosciences set a CLOVER-WaM subgroup data update on iopofosine I-131 for presentation at ASCO 2026 on June 1.Disclosure targets relapsed or refractory Waldenstrm macroglobulinemia patients who progressed on BTK inhibitors.Company also described efficacy signals as supportive of a differentiated post-BTK inhibitor option, potentially as early as second-line use.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260421:nNDL5hm0xx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CLRB","02197","NDAQ","LU0314104364.USD","IE00BN0W2V16.EUR","IE00BN0W2W23.USD","IE00BN0W2T93.GBP","LU2095319765.USD","SG9999014021.USD","BK1161","IE00BKPKM429.USD","LU2210150020.SGD","BK4588","LU2210149790.SGD","SG9999014013.SGD","IE00BGHQF748.EUR","IE00B64PRP62.GBP","SG9999014005.SGD","IE00B3QW5Z07.USD","SG9999014039.USD","BK4585","BK4112","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627044623","title":"Cellectar enrolls first patient in Phase 1b CLR 125 trial for TNBC","url":"https://stock-news.laohu8.com/highlight/detail?id=2627044623","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627044623?lang=en_us&edition=fundamental","pubTime":"2026-04-14 20:36","pubTimestamp":1776170192,"startTime":"0","endTime":"0","summary":"Cellectar Biosciences enrolled first patient in Phase 1b trial of CLR 125, an iodine-125 radioconjugate, in relapsed or refractory triple negative breast cancer.Trial will assess safety, tolerability, tumor targeting, and early signs of anti-tumor activity, with no clinical results presented yet.Management plans to report dosimetry, safety, and efficacy updates throughout 2026.Program builds on clinical experience with iopofosine I-131, while positioning CLR 125 as a differentiated candidate with a distinct therapeutic profile.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260414:nNDL8SQfx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210149790.SGD","IE00BN0W2W23.USD","LU2210150020.SGD","IE00BGHQF748.EUR","IE00B3QW5Z07.USD","CLRB","BK4588","LU2095319765.USD","BK4585","SG9999014013.SGD","SG9999014039.USD","IE00B64PRP62.GBP","IE00BN0W2V16.EUR","NDAQ","SG9999014021.USD","LU0314104364.USD","IE00BN0W2T93.GBP","IE00BKPKM429.USD","SG9999014005.SGD","BK4139","BK4112"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":3,"totalSize":72,"code":"91000000","status":"200"}]}}